Emcure signs agreement with Gilead for manufacture and supply of Lenacapavir
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
This is used to treat central diabetes insipidus and bedwetting
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Enzalutamide Tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
The product is expected to be launched in Q3FY25
Subscribe To Our Newsletter & Stay Updated